Epidemiology


Etiology


Pathophysiology


Clinical features


  • Main symptoms: dermatomal distribution, typically affecting 1–3 dermatomes on one side of the body (most commonly affects the cervical, trigeminal, thoracic, and lumbar dermatomes)
    • Pain
      • The most frequent symptom and may precede the rash
      • Usually described as “burning”, “throbbing”, or “stabbing”
      • Allodynia may occur.
    • Erythematous maculopapular rash that quickly evolves into vesicular lesions
      • Vesicles are initially clear.
      • Pustulation and rupture typically occur after 3 or 4 days.
      • Crusting and involution typically occurs between day 7 and 10.
      • Lesions may become necrotic, generalized, or may not be present at all.
  • Additional symptoms
    • Fever, headache, and fatigue

Subtypes and variants


Herpes zoster ophthalmicus (HZO)

  • Definition: reactivation of VZV in the ophthalmic division of the trigeminal nerve
  • Clinical features
    • Fever and skin symptoms as in shingles
    • Herpes zoster conjunctivitis
    • Herpes zoster keratitis
    • Involvement of the ophthalmic nerve: reduced corneal sensitivity with severe pain in the innervated regions (forehead, bridge and tip of the nose)
    • Involvement of the nasociliary nerve:
      • Possible severe intraocular infection (uveitis, iritis, conjunctivitis, keratitis, and optic neuritis)
      • Positive Hutchinson sign of the nose: a vesicular rash on the nasal alae

Diagnostics


Positive Hutchinson sign of the nose: a vesicular rash on the nasal alae

Treatment


Complications


Postherpetic neuralgia

  • Definition: chronic neuropathic pain persisting for at least three months in the area previously affected by the rash
  • Epidemiology
    • Most common complication (occurs in 10–20% of overall herpes zoster cases)
    • Strong association with age
  • Risk factors
    • Age > 50 years
    • Severe infection (severe pain or rash)
  • Clinical features
    • Pain (including allodynia, paresthesias, dysesthesias) in the same dermatome as the rash
    • Duration of symptoms > 3 months but can persist for years
  • Treatment
    • One of the following tricyclic antidepressants:
      • Reduces serotonin and norepinephrine at the same time
      • Amitriptyline
      • Nortriptyline
      • Relative contraindications: patients with heart disease, epilepsy, or glaucoma
      • Should be used with caution in elderly patients
    • One of the following anticonvulsants:
      • Pregabalin
      • Gabapentin
    • Topical treatments
      • Capsaicin patch or cream